Quest Partners LLC reduced its position in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 80.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,067 shares of the company’s stock after selling 8,488 shares during the period. Quest Partners LLC’s holdings in DocuSign were worth $128,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in DOCU. Inspire Investing LLC purchased a new stake in shares of DocuSign during the 3rd quarter valued at $911,000. Comerica Bank raised its position in DocuSign by 228.8% during the first quarter. Comerica Bank now owns 28,901 shares of the company’s stock valued at $1,721,000 after purchasing an additional 20,110 shares in the last quarter. International Assets Investment Management LLC raised its position in DocuSign by 5,660.8% during the third quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock valued at $27,252,000 after purchasing an additional 431,295 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its holdings in shares of DocuSign by 7.1% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock worth $80,501,000 after purchasing an additional 85,987 shares in the last quarter. Finally, Carrera Capital Advisors purchased a new position in shares of DocuSign in the 3rd quarter worth about $666,000. Institutional investors own 77.64% of the company’s stock.
Insider Activity
In other DocuSign news, CEO Allan C. Thygesen sold 7,725 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $59.09, for a total value of $456,470.25. Following the completion of the sale, the chief executive officer now owns 102,193 shares of the company’s stock, valued at $6,038,584.37. This trade represents a 7.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Blake Jeffrey Grayson sold 14,036 shares of the firm’s stock in a transaction that occurred on Wednesday, September 18th. The stock was sold at an average price of $55.47, for a total value of $778,576.92. Following the sale, the chief financial officer now directly owns 87,611 shares of the company’s stock, valued at $4,859,782.17. This represents a 13.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 69,558 shares of company stock worth $4,272,768. 1.66% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
Check Out Our Latest Report on DocuSign
DocuSign Stock Performance
NASDAQ DOCU opened at $80.38 on Friday. The business’s fifty day moving average is $71.56 and its 200 day moving average is $60.93. DocuSign, Inc. has a fifty-two week low of $42.13 and a fifty-two week high of $86.75. The company has a market capitalization of $16.31 billion, a PE ratio of 16.96, a price-to-earnings-growth ratio of 9.05 and a beta of 0.90.
DocuSign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings data on Thursday, September 5th. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.80 by $0.17. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The firm had revenue of $736.03 million for the quarter, compared to the consensus estimate of $727.20 million. During the same period last year, the firm earned $0.09 EPS. The company’s revenue was up 7.0% on a year-over-year basis. On average, sell-side analysts forecast that DocuSign, Inc. will post 1.01 EPS for the current year.
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also
- Five stocks we like better than DocuSign
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is the S&P 500 and How It is Distinct from Other Indexes
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Investing in Travel Stocks Benefits
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.